Immunoreactivity for TRK was easily identifiable, as the majority of the positive CRC and NSCLC cases showed diffuse moderate to strong intensity staining except for one case harboring ETV6–NTRK3 fusion. Here, TPM3 is linked to non-small cell lung carcinoma.